3 ASX 200 shares that could beat the market over the next 10 years

Outperforming the market isn't easy, but some companies have the qualities needed to do it.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Trying to outperform the market is not easy. But it is possible.

I think by focusing on ASX 200 shares with lasting advantages, long growth runways, and the ability to compound earnings at an attractive rate, investors have a chance at beating the market.

With that said, here are three shares that I believe have a genuine shot at outperforming over the next 10 years.

Woman with an amazed expression has her hands and arms out with a laptop in front of her.

Image source: Getty Images

Goodman Group (ASX: GMG)

One of the first names that comes to mind for me is Goodman Group.

I do not really see it as a traditional property business. To me, it looks more like a global infrastructure platform that is tied to some of the most important trends in the economy right now.

Its exposure to logistics is already compelling, but what really stands out is its push into data centres.

With demand for cloud computing and artificial intelligence (AI) infrastructure continuing to grow, I believe Goodman is well positioned to benefit. Its access to strategic land, power, and capital gives it a meaningful edge in delivering these projects.

Over a decade, I think those advantages could translate into strong earnings growth.

Pro Medicus Ltd (ASX: PME)

Pro Medicus is a company I find particularly interesting because of how specialised its offering is.

It operates in medical imaging software and has built a reputation for delivering high-performance solutions to major hospitals and healthcare providers.

What I like most is its business model. It tends to win long-term contracts with high-value clients, which can provide recurring revenue and strong margins. On top of that, it has been expanding into other ologies and leveraging AI.

The valuation is still not conventionally cheap despite a heavy share price decline this year. But in my view, businesses with strong competitive positioning and global growth opportunities often command a premium for a reason.

WiseTech Global Ltd (ASX: WTC)

WiseTech is another company that I think fits the profile of a long-term compounder.

Its software platform, CargoWise, is deeply embedded in global logistics operations. That creates a level of stickiness that I believe is difficult for competitors to replicate.

As global trade continues to evolve and digitise, I see ongoing demand for more efficient and integrated logistics solutions.

What I find compelling is that once customers are on the platform, switching can be complex and costly. That can help support pricing power and long-term customer retention.

While there is some uncertainty with changes to its business model, if it executes successfully, it could set WiseTech up for strong and sustainable growth long into the future. 

For this reason, I think it has potential to beat the market over the next 10 years.

Foolish takeaway

Outperforming the market is never guaranteed, and even high-quality companies can go through periods of underperformance.

But when I look at these three ASX 200 shares, I see businesses with strong fundamentals, clear growth drivers, and the potential to compound over time.

If I were building a portfolio with a 10-year horizon, these are the types of companies I would want to own.

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended Goodman Group and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Two smiling work colleagues discuss an investment at their office.
Growth Shares

Why I'd buy and hold Pro Medicus and DroneShield shares

These are two shares where I am much more interested in what the businesses could become than what happens over…

Read more »

Woman with her kitten on a laptop in her home office.
Growth Shares

3 top ASX shares for beginners to buy now

I think starting with businesses you can actually understand makes the ups and downs of investing much easier to handle.

Read more »

Happy investor on tablet with finance graphs rising in overlay.
Growth Shares

2 ASX shares I want to hold until 2030 and beyond

Both businesses have already achieved plenty. The amount of growth still available is why I would want to own them…

Read more »

flying asx share price represented by man flying remote control drone
Growth Shares

Why are DroneShield shares suddenly rising again?

A guidance miss, then a sharp bounce. What changed?

Read more »

Person handing out $50 notes, symbolising ex-dividend date.
Growth Shares

Where I'd invest $25,000 into ASX shares in August

I outline why these shares could be top picks for investors this month and for years to come.

Read more »

A female soldier flies a drone using hand-held controls.
Growth Shares

ASX defence shares have been the trade of the decade. Is it too late to join the party?

Order books are growing. Share prices aren't.

Read more »

Group of people cheer around tablets in office
Growth Shares

3 growing ASX 300 shares I'd buy with $5,000

All three businesses have something to prove, but strong execution could make them considerably larger over time.

Read more »

Excited couple celebrating success while looking at smartphone.
Growth Shares

5 ASX shares I'd buy with $5,000 in August

I think these ASX 200 shares are now trading below fair value.

Read more »